Personalized Atrial Fibrillation Ablation with AI, IoT, and Blockchain Integration
Legal Citation
Summary of the Inventive Concept
A novel system for personalized atrial fibrillation ablation, integrating artificial intelligence, IoT, and blockchain technologies to improve treatment outcomes and patient care.
Background and Problem Solved
The original patent addresses the limitations of conventional atrial fibrillation ablation treatments by utilizing a three-dimensional model of the patient's heart to produce a personalized ablation catheter. However, the new inventive concept takes this a step further by incorporating AI, IoT, and blockchain technologies to create a more comprehensive and efficient system.
Detailed Description of the Inventive Concept
The new system comprises a three-dimensional model of the patient's heart generated using artificial intelligence, an ablation catheter customized based on the model, and a blockchain-based tracking system for monitoring treatment outcomes. The system also utilizes IoT-enabled devices for real-time monitoring and control of the ablation procedure. Additionally, the ablation device features a nanomaterial-based coating for improved biocompatibility and reduced tissue inflammation.
Novelty and Inventive Step
The new claims introduce the integration of AI, IoT, and blockchain technologies, which is not present in the original patent. The combination of these technologies with the personalized ablation catheter provides a novel and non-obvious solution for improving treatment outcomes and patient care.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms for generating the three-dimensional heart model, varying IoT device configurations for real-time monitoring, and alternative blockchain-based data storage systems. Additionally, the system could be adapted for use in other cardiac arrhythmia treatments.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the cardiac arrhythmia treatment market, which is projected to grow significantly in the coming years. The system's ability to improve treatment outcomes and patient care makes it an attractive solution for hospitals, clinics, and medical device manufacturers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B34/10 |
| A | A61 | A61B18/1492 |
| A | A61 | A61B2017/00526 |
| A | A61 | A61B2018/00375 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2034/104 |
| A | A61 | A61B2034/105 |
| A | A61 | A61B2090/374 |
| A | A61 | A61B2090/378 |
| A | A61 | A61B2090/3762 |
| A | A61 | A61M25/0009 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technology, Specifically Cardiac Intervention and Ablation Systems, Requiring Advanced Knowledge in Biomedical Engineering, Medical Imaging, AI/Machine Learning, and Interventional Cardiology
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or interventional cardiologist with advanced technical training, proficient in medical device design, 3D modeling, AI/machine learning techniques, and understanding of cardiac anatomy and intervention strategies
Obviousness Rationale
A PHOSITA would recognize that integrating emerging technologies like AI, IoT, and blockchain into existing personalized ablation systems represents a natural technological progression. The core ablation methodology remains consistent with the source patent, while the proposed technological enhancements provide predictable improvements in treatment precision, monitoring, and data management. These technological integrations represent incremental innovations that would be obvious to a skilled practitioner seeking to optimize medical device performance and patient outcomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,263 |
|---|---|
| Title | Personalized atrial fibrillation ablation |